SinoMab BioScience Limited (3681.HK)
HKD 1.03
(-1.9%)
HKD 1.03
(-1.9%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.24 CNY | 17.24% |
| 2022 | -0.29 CNY | 0.0% |
| 2021 | -0.29 CNY | -141.67% |
| 2020 | -0.12 CNY | 63.64% |
| 2019 | -0.33 CNY | -297.11% |
| 2018 | -0.08 CNY | -74.21% |
| 2017 | -0.05 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.08 CNY | 0.0% |
| 2023 Q4 | -0.11 CNY | 0.0% |
| 2023 Q2 | -0.13 CNY | 0.0% |
| 2023 FY | - CNY | 17.24% |
| 2022 FY | - CNY | 0.0% |
| 2022 Q4 | -0.14 CNY | 0.0% |
| 2022 Q2 | -0.15 CNY | 0.0% |
| 2021 Q2 | -0.11 CNY | 0.0% |
| 2021 Q4 | -0.18 CNY | 0.0% |
| 2021 FY | - CNY | -141.67% |
| 2020 Q2 | -0.08 CNY | 0.0% |
| 2020 FY | - CNY | 63.64% |
| 2020 Q4 | -0.04 CNY | 0.0% |
| 2019 Q2 | -0.06 CNY | 29.78% |
| 2019 FY | - CNY | -297.11% |
| 2019 Q4 | -0.26 CNY | 0.0% |
| 2019 Q1 | -0.08 CNY | 0.0% |
| 2018 Q1 | -0.02 CNY | 0.0% |
| 2018 FY | - CNY | -74.21% |
| 2018 Q4 | -0.08 CNY | 0.0% |
| 2018 Q2 | -0.02 CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | -0.01 CNY | 0.0% |
| 2017 Q2 | -0.01 CNY | 0.0% |
| 2017 Q4 | -0.02 CNY | 0.0% |
| 2016 Q4 | -0.01 CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 2262.162% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 13433.333% |